genedrive plc is focused on decentralising molecular diagnostics, concentrating on applications where our technology will provide sustainable growth
Diagnostics: Rapid and accurate diagnosis of infectious disease facilitating immediate therapeutic treatment.
Pharmacogenomics: Allowing medicine to be personalised around an individual patient's genotype.
Future applications: Genedrive® is being validated for use in the areas of pathogen detection & biosurveillance and aquaculture.
genedrive plc at a glance >
Share price details >
View all regulatory news >
05 April 2024
Interim Presentation 31 December 2023
View all reports >
Saturday July 20, 2024
Small-cap movers: AIM exodus continues as three more head for the door
Monday July 15, 2024
Genedrive jumps a third after US regulatory thumbs up
Friday May 31, 2024
Small-cap movers: Quadrise up on new client wins
View all news >
This site uses cookies for tracking and statistical purposes. Please read our privacy policy for more information.
Don't show this again